Search results for "Highlights"
Guideline recommends standardized management of mild to moderate ulcerative colitis
The guideline focuses on oral and topical 5-aminosalicylic acid medications, rectal corticosteroids, and oral budesonide in patients with mild to moderate disease.
https://gastroenterology.acponline.org/archives/2018/12/28/2.htm
28 Dec 2018
Individual or group hypnotherapy associated with relief from IBS
Although hypnotherapy did not improve quality of life, psychological symptoms, cognition, self-efficacy, or irritable bowel syndrome (IBS) symptoms significantly more than an educational support program, it may provide relief to patients by changing their perception of IBS.
https://gastroenterology.acponline.org/archives/2018/12/28/3.htm
28 Dec 2018
Patients may not always want to stop low-value colorectal cancer screening
Veterans at one health system were asked to rate the reasonableness of using age and risk calculators in decisions about screening cessation.
https://gastroenterology.acponline.org/archives/2018/12/28/1.htm
28 Dec 2018
Combination therapy for IBD carries higher infection risk than monotherapy
Monotherapy for inflammatory bowel disease (IBD) with an immunosuppressive agent was associated with a lower risk of serious infection than a tumor necrosis factor (TNF) antagonist alone or an anti-TNF plus an immunosuppressive agent, according to a meta-analysis.
https://gastroenterology.acponline.org/archives/2019/03/22/2.htm
22 Mar 2019
Statins associated with lower risk for postcolonoscopy colorectal cancer
The primary outcome of the retrospective cohort study was postcolonoscopy colorectal cancer within three years, defined as colorectal cancer diagnosed within six and 36 months after negative findings on index colonoscopy.
https://gastroenterology.acponline.org/archives/2019/03/22/3.htm
22 Mar 2019
Daily aspirin may reduce risk of hepatitis-related liver cancer
A Taiwanese nationwide cohort study of more than 10,000 patients with chronic hepatitis B showed a statistically significant 29% risk reduction for hepatocellular carcinoma in patients who received daily aspirin compared with matched controls.
https://gastroenterology.acponline.org/archives/2019/03/22/1.htm
22 Mar 2019
Efficacy, safety of second-line therapies analyzed for two types of IBS
A systematic review and network meta-analysis focused on alosetron, eluxadoline, ramosetron, and rifaximin in adult patients who had irritable bowel syndrome (IBS) with diarrhea or mixed stool.
https://gastroenterology.acponline.org/archives/2019/04/26/2.htm
26 Apr 2019
Beta-blockers linked to better outcomes in some patients with cirrhosis
Decompensation-free survival improved in patients with cirrhosis and portal hypertension who received beta-blockers versus placebo, largely due to a decrease in ascites.
https://gastroenterology.acponline.org/archives/2019/04/26/3.htm
26 Apr 2019
Lowering colorectal cancer screening age from 50 to 45 years appears cost-effective
Initiating screening at age 45 years would require an additional 10 million colonoscopies, which could potentially provide greater benefit if used instead to increase screening rates in older patients, authors of the modeling study said.
https://gastroenterology.acponline.org/archives/2019/04/26/1.htm
26 Apr 2019
PPIs in patients receiving anticoagulation may not reduce upper GI events
There was no significant difference in upper GI events between a pantoprazole group and a placebo group, although pantoprazole was associated with significantly reduced bleeding of gastroduodenal lesions, an industry-funded study found.
https://gastroenterology.acponline.org/archives/2019/05/24/3.htm
24 May 2019